
Onc.AI
AI-powered technology to bring clarity to cancer treatment decisions.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor investor investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 | round | |
* | $2.0m | Grant | |
Total Funding | 000k |
USD | 2021 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Onc.AI is a private digital health startup that operates in the oncology sector. The company's primary objective is to enhance decision-making in cancer treatment through the use of artificial intelligence (AI). Onc.AI uses a comprehensive dataset from various sources such as diagnostic imaging, electronic medical records (EMR), labs, and genomics to develop AI models. These models aim to optimize precision oncology, a method of cancer treatment that uses genetic understanding to deliver effective, personalized care.
The company's initial product is designed to assist medical oncologists in making treatment decisions for metastatic lung cancer patients undergoing PD-1 immunotherapy. PD-1 immunotherapy is a type of treatment that helps the immune system fight cancer cells.
Onc.AI's business model revolves around the development and sale of these AI models to healthcare providers, particularly those specializing in oncology. The company generates revenue by selling access to these AI models, which help healthcare providers make more informed treatment decisions.
The team at Onc.AI is composed of successful entrepreneurs, healthcare technology operators, AI/ML researchers, and computer vision experts. The company operates remotely, allowing for a diverse and distributed team. The company culture emphasizes positivity, hard work, inclusivity, and kindness.
In summary, Onc.AI is a digital health startup that leverages AI to improve decision-making in oncology. It serves healthcare providers, operates in the healthcare technology market, and generates revenue by selling access to its AI models.
Keywords: Onc.AI, Digital Health, Oncology, Artificial Intelligence, Precision Oncology, PD-1 Immunotherapy, Healthcare Providers, AI Models, Remote Work, Company Culture.